Introduction

Wall Street opened the week with a flurry of analyst notes on Friday, Oct 23, 2026, covering sectors from semiconductors to space exploration and digital retail. The day's calls set the tone for investor sentiment heading into the weekend.

What Happened

Roth initiated coverage of Natera and Guardant Health with buy ratings, citing strong growth catalysts in life sciences. PhillipCapital upgraded SpaceX to buy on bullishness around its Super Intelligence Network, projecting revenue exceeding $132 billion by 2027. Seaport maintained a sell rating on Nvidia, citing competitive pressures and aggressive finance bundling as signs of strategic tension. Barclays initiated Rush Street Interactive at overweight, highlighting underappreciated iGaming momentum and derisked near-term growth fears. Piper Sandler downgraded Deckers to underweight after a rare sales miss and lowered annual guidance, noting softness in the athletic marketplace. Jefferies upgraded MSC Industrial to buy, citing a compelling entry point after a 15% pullback and expected volume growth into 2027. Citizens initiated Microbot Medical at market outperform, while Northland started Unusual Machines at outperform, highlighting U.S. drone demand. Needham began coverage of DIOD with a buy and $110 price target, citing margin expansion. KBW upgraded Valley National to outperform, pointing to a valuation discount and strong NII/NIM growth. Raymond James upgraded Hess Midstream to outperform after a selloff following Chevron restructuring. JPMorgan downgraded Norwegian Cruise to underweight over geopolitical headwinds in Europe. Morgan Stanley reiterated CoreWeave as equal weight but lowered the price target to $70, citing financing uncertainty. Morgan Stanley also named CBOE and Pinnacle Financial Partners as top picks, while Bank of America upgraded Pharvaris and Allegion. Cantor Fitzgerald initiated Quantum Corp at overweight, describing a transformation from legacy tape vendor to interesting data management player. UBS reiterated CoreWeave as buy, lowering the target to $105.

Why This Matters

The breadth of Friday's calls underscores how quickly analyst sentiment can shift across tech, healthcare, retail and energy sectors. SpaceX's upgrade signals growing confidence in private space infrastructure, while CoreWeave's mixed signals reflect financing risks in the neocloud space. Deckers' downgrade and Nvidia's sell caution highlight sector-specific headwinds, and new initiations in biotech and drones suggest emerging opportunities for targeted exposure.

Key Takeaways

  • SpaceX upgraded to buy with revenue projections exceeding $132 billion by 2027.
  • CoreWeave maintained equal weight but saw price target cut to $70 on financing visibility.
  • Deckers downgraded to underweight after rare sales miss and lowered guidance.
  • Nvidia maintained sell rating amid competitive pressure concerns.
  • New initiations in biotech (Natera, Guardant Health) and drone tech (Unusual Machines, Microbot Medical) signal growth areas.
  • Barclays and Morgan Stanley initiated top picks in iGaming and prediction markets, respectively.

Conclusion

Key takeaways from Friday's notes suggest investors should monitor follow-up research on SpaceX momentum, CoreWeave financing developments, and Deckers' recovery path. Market sentiment remains sensitive to sector-specific catalysts and broader macro trends.